mrs introduction

97
MRS Dr Prem Kumar C MD

Upload: hai2all2000-yahoo

Post on 24-May-2015

1.117 views

Category:

Education


1 download

DESCRIPTION

MR SPECTROSCOPY

TRANSCRIPT

Page 1: MRS INTRODUCTION

MRS

Dr Prem Kumar C MD

Page 2: MRS INTRODUCTION

MR techniques

• Contrast - Vascularity• Diffusion - Microarchitexture • Perfusion - Neo angiogenesis • Spectroscopy - Chemical environment

• Quantitative noninvasive assay of metabolites

Page 3: MRS INTRODUCTION

MR SPECTROSCOPY

• Detection of frequency dependent signals from individual metabolites

• Interpretation is based on identity of chemical and concentration

• Baseline normal spectra - constant • Concentration of each metabolites alter in a

reproducible pattern - Abnormal spectra = DISEASE PATTERN

Page 4: MRS INTRODUCTION
Page 5: MRS INTRODUCTION

Variables

• Height • width size & Frequency of each

peak

• Combining horizontal and vertical information• Presence / absence of peak• Ratio of metabolites

Page 6: MRS INTRODUCTION

METABOLITES

• Cho - Cell membrane turn over• Cr - Energy marker -Reference• NAA - Neuronal cell marker• mI - Osmolyte• Lactate - Anerobic state - NOT SEEN

IN NORMAL BRAIN

Page 7: MRS INTRODUCTION

Hunters angle

Gray matter has more creatine

Page 8: MRS INTRODUCTION
Page 9: MRS INTRODUCTION
Page 10: MRS INTRODUCTION

NAA Regional Variations

• NAA peak – Highest due to N acetyl group• Marker of neuronal / axonal viability and

density• Evenly distributed in Cerebral hemisphere • Less in hippocampus and cerebellum• NAA - Neuronal marker • Decreases with loss of neuronal integrity. 

Page 11: MRS INTRODUCTION

Creatine

• Energy stores. • Cr 1 - 3.0 ppm • Cr 2 - 3.9 ppm • Marker of intact brain Energy Metabolism.• Reference for interpretation of ratio.• Higher in grey matter than white matter• Higher in thalamus and cerebellum

Page 12: MRS INTRODUCTION

Choline

• Cho - 3.2 ppm • Present in Cell membrane• Cell membrane turnover• Choline released during disease from pool• Choline - Increased with increased cellular

turnover• Elevated in tumors and inflammation

Page 13: MRS INTRODUCTION

Choline Regional Variations

• Slightly higher in white matter than gray• Higher in thalamus and cerebellum• More choline in pons and terminal zones

of myelination

Page 14: MRS INTRODUCTION

Myo-Inositol

• Cell Volume Regulator - Osmolyte • mI - 3.5 ppm ; 4.0 ppm.• Present in astrocytes• Astrocyte /glial marker - Product of myelin

degradation

Page 15: MRS INTRODUCTION

Lactate

• Accelerated glycolysis /Anaerobic glycolysis• Lac - 1.3 ppm – Doublet• Inverts with TE 144 or 135 ms• Normal in preterm / term infants & CSF

contamination

Page 16: MRS INTRODUCTION

Lipids• Lip 1 - 0.9 ppm; Lip 2 - 1.3 - 1.4 ppm• Broad based • Sign of brain injury• Normally Bound - Not seen• Seen when there is cell death and cell membrane

destruction• Indicates necrosis and / or disruption of myelin• Difficult to differentiate from macromolecules• Non significant lipid – from scalp contamination

Page 17: MRS INTRODUCTION

Glutamate & Glutamine (Glx)

• Neurotransmitters• Beta, Gamma Glx - 2.0 - 2.5 ppm• Alfa Glx - 3.6 - 3.8 ppm

Page 18: MRS INTRODUCTION

• Glutamine is astrocyte marker• Glutamate – Neurotransmiter - neurotoxin in

excess amount.• Main ammonia intake route• Elevated - In hypoxia, ischemia, recovering

brain.• Its not a grave prognostic finding like lactate

Page 19: MRS INTRODUCTION

T2/FLAIR For ROI

Page 20: MRS INTRODUCTION

MRS acquisition modes

• STEAM -Stimulated echo acquisition mode• Single voxel • Short TE

• PRESS -Point resolved spectroscopy• Twice the SNR of STEAM• Short and long TE - single voxel possible

Page 21: MRS INTRODUCTION

PROBE - Single voxel proton MRS

• Fully automated prescan, scan• shimming• water suppression• 2 -6 minutes Complete acquisition• Short TE (PRESS, STEAM) and• long TE (PRESS)

Page 22: MRS INTRODUCTION

Single voxel proton MRS

Page 23: MRS INTRODUCTION

Multi voxel MRS

• Variable voxel sizes• More than one lesion• Control from normal

Page 24: MRS INTRODUCTION

Acquisition Parameters

TR - 1500 msTE - 35 msNAV - 64Voxel Size - 2 x 2 x 2 cmVoxel Location:-

Cingulate gyrus -GMParietal -WM

Page 25: MRS INTRODUCTION

Chemical Shift Imaging in TumorsSpatial distribution of metabolites

Page 26: MRS INTRODUCTION

METABOLITES

SHORT TE 35

• mI• LACTATE• LIPIDS• GLUTAMATE / GLUTAMINE

BOTH SHORT 35 AND LONG TE 144

• NAA• CREATINE• CHOLINE• LACTATE signal lowered

Page 27: MRS INTRODUCTION

Lactate Vs Lipid

• Lactate is doublet• Inversion below the baseline at 144 ms• Persists at TE 270 ms.

• Lipid peak is broad• Has a shoulder to left• Suppressed at TE 270 ms

Page 28: MRS INTRODUCTION

Lactate

TE 35 TE 144

TE 270

Page 29: MRS INTRODUCTION

LIP-LACTATE

Page 30: MRS INTRODUCTION

Tumor Biochemistry

• Understood by identifying important metabolites and quantifying them.

• Comparing with normal and benign tissues, we can understand metabolite markers and grade them.

Page 31: MRS INTRODUCTION

Alteration of metabolites in Brain Tumors

• Decreased or absence of N – Acetyl Aspartate (NAA) (Non-neuronal and NAA is only found in neurons)

• Decreased Creatine• Increased Choline• Appearance of Lactate (Anaerobic glycolysis)• Myo-Inositol may distinguish hemangiopericytomas from

meningiomas• Glutamine and Glutamate are prominent in meningiomas

Page 32: MRS INTRODUCTION

FAQ

• Is it a tumour • GBM/ Metz/ Abscess?• Grade?• Survival?• ? Oligodentroglioma?

Page 33: MRS INTRODUCTION

Tumour?

• D/D -Stroke, Focal cortical dysplasia, Herpes and Neoplasm

• ^ Cho – Neoplasm• Always exclude Demylination - ^ Cho

Page 34: MRS INTRODUCTION

GBM/Metz/Abscess

• Multivoxel PRESS sequence with intermediate TE -for elevation of Cho in enhancing rim and in peri-lesional T2 hyperintensity

• If Cho is elevated in both areas - GBM• Elevated in rim; N –Around - Metz• Detection of peptides and amino acids in Short

TE - Pyogenic abscess

Page 35: MRS INTRODUCTION

Grade

• Cho/NAA ratio - Most sensitive index for tumor cell density and proliferation.

• Marker of tumor infiltration• High Cho/NAA and Cho/Cr - Fast

growing and high grade neoplasm

Page 36: MRS INTRODUCTION
Page 37: MRS INTRODUCTION
Page 38: MRS INTRODUCTION

Prognosis

• High Creatine levels in grade II gliomas- malignant transformation and poor survival

• High Cho -Pediatric brain tumors

Page 39: MRS INTRODUCTION

Oligo dentro gliomaSky-rocketing Choline - high cellular density

MR perfusion:Increased- rCBV- high capillary density low level of angiogenesis

Page 40: MRS INTRODUCTION
Page 41: MRS INTRODUCTION

Low-grade astrocytoma with elevated lactate

Page 42: MRS INTRODUCTION

High grade glial tumors

Page 43: MRS INTRODUCTION

TE 35

Page 44: MRS INTRODUCTION

TE 135

Page 45: MRS INTRODUCTION

57 yr M + LOC

After 20 days

Page 46: MRS INTRODUCTION
Page 47: MRS INTRODUCTION
Page 48: MRS INTRODUCTION

Key points

• High Cho - High tumor cell density & high vascular proliferation.

• Low Cho and elevation of lipids - Necrosis.• Cho higher enhancing rim -may be the faster growing

side of the tumor. • Vasogenic edema -Normal Cho and slightly decreased

NAA.

Page 49: MRS INTRODUCTION

Spectra of active demyelination indistinguishable from gliomas.MR perfusion may be helpful.

41y focal seizure

Tumefactive multiple sclerosis

Page 50: MRS INTRODUCTION

• Alanine (Ala) doublet at 1.4 ppm• Elevation of Cho• Presence of Lac at 1.3 ppm.• Absent NAA - Non-neural origin.

• Ala -30–40% of Meningioma• Mobile lipid and high Cho -

aggressive lesions

43 y Focal deficit

Page 51: MRS INTRODUCTION

Recurrent astrocytoma24 y post Rx

Page 52: MRS INTRODUCTION

Recurrent astrocytoma

• Normal -1 Infiltrative -2• Solid -3 Early necrotic -4• All with high Cho/ Cr >1.7• High Cho, very low NAA and no lipid -Solid

tumor. • Small Lac without lipid may be early indicator

of transformation to high grade.

Page 53: MRS INTRODUCTION

• 51y M, GBM Rx RT.

• Reduced Cho, NAA and Cr relative to normal brain indicates necrosis.

Page 54: MRS INTRODUCTION

Stroke

• Localized decreased NAA - few hours of ischemia.• Very low or absent – chronic infarcts.• Lac is elevated in acute stroke due to anaerobic glycolysis in

ischemic brain.• Creatine and Choline may change in acute and chronic stroke. • Lipid - Reflect necrosis.• MRS is added value to diffusion and perfusion

Page 55: MRS INTRODUCTION

Occlusion of the left ICA /MCA @ 24 h

Left - Elevated Lac and near absent NAA

Page 56: MRS INTRODUCTION

Occlusion of Right ICA

Page 57: MRS INTRODUCTION

With in 24 hr

Lac- ElevatedNAA- Preserved

Follow-up @ 1 wk

absence of NAALac in infarct region. High Cho in peri infarct WM

Follow-up @ 5 m

Reduced NAAhigh Cho in WMNo LacLipid + in infarcted right basal ganglia.

Page 58: MRS INTRODUCTION

Pyogenic meningitis

large amount of amino acids -1, lactate -2, alanine -3, acetate -4,acetoacetate -5

Page 59: MRS INTRODUCTION

Pyogenic abscess

135 TEInv Of AA,0.9 ppm, Lac, 1.33 ppm, and Ala, 1.47 ppm peaks

Page 60: MRS INTRODUCTION

TUBERCULOMA

Page 61: MRS INTRODUCTION

• Similar on MRI.• Tuberculous abscesses - only Lac and lipid signals @

0.9 and 1.3 ppm; No amino acids • Lipid peaks –In Both tuberculoma and pyogenic

abscess. • Amino acid signals helps to discriminate pyogenic

from tuberculous abscess

• @ 135 TE Inv of AA- 0.9 ppm

Tuberculous vs Pyogenic abscesses

Page 62: MRS INTRODUCTION

Tuberculous abscessesSTEAM

TE 35, only Lip and Lac at 1.3 ppm.

TE 135 spectrum, phase reversal & reduction in signal

Page 63: MRS INTRODUCTION

HSE

Findings are due to interstitial edema; MRS - Non-specific.

Page 64: MRS INTRODUCTION

Fungal abscess

• TE 135 proton MR spectrum from core of abscess - inverted AA and Lac peaks.

• Multiple signal (*) @ 3.6–3.8 ppm- trehalose

Page 65: MRS INTRODUCTION

Hydatid cyst:

MRS with TE 35 - Lac at 1.33 ppm,acetate at 1.92 ppm, and succinate at 2.4 ppm;

@TE 135 - Lac and Ala at 1.5 ppm show phase reversal while Ace and Suc show normal phase.

Page 66: MRS INTRODUCTION

Neurocysticercosis

• Spectroscopy may be of value in the large cysticercus cyst without visible scolex, where differential diagnosis includes brain abscess and cystic metastases.

• In vivo MRS shows acetate, succinate and Lac.

• Presence of Cr depending on whether the lesion is in the vesicular or colloid stage

Page 67: MRS INTRODUCTION

HIV encephalopathy

• Reductions in NAA and increases in Cho, mI in both lesional and normal appearing brain tissues.

• Toxoplasmosis Vs lymphoma– Toxoplasmosis -Very large lipid signals– Lymphoma -Large lipid (smaller than toxo)

-High Cho (not seen in toxo).

Page 68: MRS INTRODUCTION

D/D

Page 69: MRS INTRODUCTION

Demyelination

Multiple sclerosis - Axonal damage - Decreased NAA

Demyelination - Increased mI, Cho.

Acute MS plaques - Decreased NAA and Cr in large plaques

Increased mI, Cho and Lac

Chronic plaque - Cr and Lac return quickly to normal,

Cho - months to return to normal

NAA -may or may not recover to normal.

Tumefactive demyelination may be similar to neoplasm (elevated Cho, Lac, decreased NAA) –Perfusion useful.

Monophasic Acute Disseminated Encephalo Myelitis - Mild, reversible NAA reductions without changes in other metabolites - Good prognosis.

Page 70: MRS INTRODUCTION

Multiple sclerosis

• Long TE spectra in acute and chronic MS lesions.– Both - Elevated Cho and reduced NAA– Only acute lesion - Elevated lactate

• Short TE spectra from acute lesion and normal brain for comparison– Increased mI, choline, and lipids, slightly

decreased Cr and NAA.

Page 71: MRS INTRODUCTION
Page 72: MRS INTRODUCTION

Acute Vs Chronic Plaque

• During acute phase- focal increases in Cho and Lac and decreases in NAA, Cr.

• 15 m later - Reduction of lesion and normalization of Cho, Cr, and Lactate. NAA- partial recovery.

Page 73: MRS INTRODUCTION

Seizure disorders• Help in localize and characterize epileptogenic

foci.• Helps in lateralizing in temporal lobe epilepsy• @35TE: Decreased NAA, Increased Cho and

mI - Gliosis• MRS may help to characterize epileptogenic

lesions visible on MRI (aggressive vs. indolent neoplasia, dysplasia)

Page 74: MRS INTRODUCTION

TLE

Ipsilat MRS:

Reduced NAA signal and increased Cho and mI signals- Gliosis

Helpful in identification of seizure focus in refractory pts with normal MR

Contralateral MRS:

Reversible with time - transient neuronal dysfunction.

Bilateral metabolic changes, associated with poor post-op seizure outcome

Page 75: MRS INTRODUCTION

Aging and dementia

• Aging - Cho and Cr increase and NAA stable• AD – Reduced NAA and High mI• NAA/Cr and mI/Cr ratios correlate with

cognitive function in AD, and this correlation is more significant with NAA/mI ratios.

• WM NAA/Cr is lower in VaD –than AD

Page 76: MRS INTRODUCTION

• Progression of AD - Regional elevation of mI/Cr levels in prodromal AD

• mI/Cr and NAA/Cr - useful for predicting and monitoring prodromal AD.

AD

Page 77: MRS INTRODUCTION

Neurodegenerative diseases

• Neuronal dysfunction & cell death.• Metabolite changes in idiopathic Parkinson’s

disease are inconsistent.• Multiple system atrophy -reduction in NAA

and NAA/Cr ratio when compared with IPD.• Lactate increased in Huntington’s disease.

Page 78: MRS INTRODUCTION

Traumatic brain injury

• Conventional CT and MR – major role• High lactate levels - Poor outcome.• Visible Lac in normal appearing brain

soon after injury - Poor outcome• Fall in NAA - Continue for months after

the initial insult.

Page 79: MRS INTRODUCTION

3 Mon after

injury

Page 80: MRS INTRODUCTION

Hypoxic brain injury

• Loss of NAA, increase in Lac and glutamine and decrease in Cr

• High Lac; low NAA and Cr -Bad prognosis.

Page 81: MRS INTRODUCTION

In severe HIE distinction

between poor prognosis

and good prognosis is

made on basis of:

(1) excess Lac

(2) decreased NAA

(3) loss of Cr

Page 82: MRS INTRODUCTION

Pediatric white matter disease

• Reduced axonal integrity - Reduced NAA

• Demyelination -High cho and mI• Hypomyelination or Gliosis -low

Cho, normal NAA

Page 83: MRS INTRODUCTION

MLD

Loss of NAA and elevation of mI

Page 84: MRS INTRODUCTION

Adrenoleukodystrophy

• Most common leukodystrophy in children• Zones- demylination, inflamm, gliosis• MRI often precede clinical symptoms showing

symmetrical WM lesions in parietal and occipital regions.

• MRS - Onset of demyelination and extent of WM damage, information for Hemo Stem Cell Transplant.

Page 85: MRS INTRODUCTION
Page 86: MRS INTRODUCTION

Inborn errors of metabolism

• Canavan and Salla disease show an elevated NAA• Maple syrup urine disease -Branched-chain amino

acids at 0.9 ppm.• Phenylketonuria -Small phenylalanine signal at

7.36ppm (i.e. downfield of water)• Non-ketotic hyperglycinemia -Glycine at 3.55 ppm

(use long TE to distinguish from mI)

Page 87: MRS INTRODUCTION

Canavan’s disease- AR

• Deficiency of aspartoacylase an enzyme that deacetylates NAA, Increased free acetate

• Hypotonia and macrocephaly• Symmetrical confluent subcortical WM T2

prolongation & Centripetal spread• Bilateral involvement of globi pallidi, thalami,

cerebellum and brainstem

Page 88: MRS INTRODUCTION

NAA is elevated in posterior sub cortical WM (1) that is hyper intense on T2 image;

NAA is near normal levels in (2) is relatively spared by signal abnormality

Page 89: MRS INTRODUCTION

Maple syrup urine disease

• Deficiency of branched-chain -keto acid dehydrogenase, catalyzing essential branched-chain amino acids (BCAA) isoleucine, leucine and valine.

• Hypertonia and hypotonia, irregular respiration and apnea• Diffusion restriction compatible with cytotoxic edema in pons,

midbrain, pallidi, thalami, cerebellar, and periventricular WM• Abnormal peak at 0.9 ppm due to accumulation of lactate

(Lac) and loss of NAA• Prognostic value & monitor response to Rx / diet• TE 136 ms- avoids lipids

Page 90: MRS INTRODUCTION

Elevation of Lac (1.3 ppm) and of the methyl group of BCAA/BCKA (0.9 ppm).

After therapy at day 12 the two abnormal peaks have disappeared.

Page 91: MRS INTRODUCTION

Phenylketonuria

• Phe hydroxylase def• Periatrial and periventricular WM symmetrical

hyperintensities.• Calcifications bilaterally in the globi pallidi

and frontal subcortical regions• Elevated Phe signal at 7.36 ppm

Page 92: MRS INTRODUCTION

Phe signal at 7.36 ppm

Page 93: MRS INTRODUCTION

Non-ketotic hyperglycinemia

• Highly elevated glycine in the CSF and absence of ketoacidosis

• Large glycine peak at 3.55 ppm• Long TE is necessary to distinguish glycine

resonance from that of mI at 3.56 ppm which is normally high in neonates

Page 94: MRS INTRODUCTION

abnormal elevation of Gly at 3.55 ppm with a Gly/Cr ~ 1.

Progressive decrease of Gly during treatment with a protein restriction diet

Page 95: MRS INTRODUCTION

Mitochondrial encephalopathy

• Diffuse symmetrical hyperintensity and volume loss in WM

• mild Lac accumulation in WM, with moderate NAA and mild Cho and Cr signal losses

Page 96: MRS INTRODUCTION

Multivoxel TE 136 ms at centrum semiovale level

Page 97: MRS INTRODUCTION

Thank You